We are leaders in research and innovation in ophthalmology
Scientific leadership for clinical excellence
Research, development, and innovation are strategic pillars that drive our growth, provide unique value to our professionals and patients, and simultaneously raise the standards of clinical care.
In recent years, we have produced over 200 scientific publications in the most prestigious and high-impact international journals, consolidating our position as the leading group in scientific output in the sector. Nearly half of our research projects are conducted in collaboration with colleagues from other countries, reflecting our strong international presence.
This scientific leadership is supported by intense research activity in three major thematic areas: anterior segment, posterior segment, and technology and basic research. These areas cover diverse lines such as new surgical techniques, advanced therapies, and technological development, all fully aligned with our clinical strengths—refractive surgery, ocular surface, and retina—directly translating into better patient care and outcomes.
R&D&I at Miranza not only generates knowledge. It drives our vision for the future and allows us to continuously elevate excellence in patient care every day.

Research areas

Medical retina and innovative therapies

Genetics of inherited ocular diseases
We research today
so our patients
can see better tomorrow
R&D&I team
Learn more about our projects
Impact Map

Miranza Centers
with R&D&I
Click here for more information
- Miranza Begitek
- Miranza IBO
- Miranza IOA
- Imo Barcelona Grupo Miranza
- Miranza COI
- Vissum Alicante Grupo Miranza
- Miranza Oculsur Jerez
- Miranza Clínica Muiños
- Miranza Clínica Pérez Silguero
- Miranza Clínica El Brillante
- Miranza Okular
- Miranza Santander
- Miranza Begoña
- Miranza Galicia
- Miranza Ophthalteam
- Miranza Albacete
- Miranza Virgen de Luján
- IMO Madrid Grupo Miranza
- Miranza Clínica Palomares
- Miranza Tecnoláser
- Miranza Sevilla
Collaborations
R&D&I Spain
Click here for more information
- 2Eyesvision
- Aonides
- AST Products Inc
- Brill Pharma
- Cornea Project S.L.
- Hospital Universitario Puerta del Hierro Majadahonda
- Iron Mountain
- Laboratorios Echevarne
- Laloslab
- Megalab
- Ophtec
- Pivotal Bcn-Peptides
- Universidad Autónoma de Madrid
- Universidad Complutense de Madrid
- Universidad de Alicante (Ua)
- Universidad de Sevilla
- Universidad Miguel Hernández (Umh)
- Universitat Politecnica de Catalunya (Upc)
- Vision Medica 2000 España S.L.
- Xenon Pharmaceuticals Inc.
- Universidad Internacional de Cataluña
Collaborations
International R&D&I
Click here for more information
- Dompé Farmaceutici S.p.A. · Italy
- Aarhus Universitets Hospital · Denmark
- Abbvie Inc. · USA
- Akkolens Clinical B.V. · Netherlands
- Alcon · Sweden
- Astellas Pharma · Japan
- Bayer Healthcare · Germany
- Cso (Italy) · Italy
- Eyebiotech Ltd (Eyebio) · United Kingdom
- Gyroscope (Novartis) · Sweden
- Johnson & Johnson · USA
- Ocumension · China
- Rayner · USA
- Recornea · Italy
- Regeneron Pharmaceuticals Inc. · USA
- Sifi Spa · Italy
- Staar Surgical · USA
- University Of Calogne · Germany
- Viena Institute For Research In Ocular Surgery (Viros) ·
- Austria
- Roche · Sweden
- Veonet · Alemania, Suiza, Netherlands,
- Reino Unido, Ireland
Partners
National:



















International:







































